Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2− Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy
Crossref DOI link: https://doi.org/10.1007/s12325-016-0328-3
Published Online: 2016-05-23
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hao, Yanni
Li, Nanxin
Fang, Anna P.
Koo, Valerie
Peeples, Miranda
Kageleiry, Andrew
Wu, Eric Q.
Guérin, Annie
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (US)
Text and Data Mining valid from 2016-05-23